Cargando…
5613004 NEWBORN SCREENING FOR SICKLE CELL DISEASE IN GERMANY - THE FIRST YEAR
Autores principales: | Lobitz, S., Kunz, J.B., Ceglarek, U., Grosse, R., Hakimeh, D., Holtkamp, U., Jarisch, A., Klein, J., Kulozik, A.E., Mirtschink, P., Murko, S., Neisse, T., Nennstiel-Ratzel, U., Oevermann, L., Rödel, M., Rönicke, S., Sinemus, N., Winter, T., Cario, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112619/ http://dx.doi.org/10.1097/01.HS9.0000928324.10147.ea |
Ejemplares similares
-
Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany—A Brief Narrative Review
por: Lobitz, Stephan, et al.
Publicado: (2021) -
Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome
por: Kunz, Joachim B., et al.
Publicado: (2021) -
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021) -
P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
por: Allard, P., et al.
Publicado: (2022) -
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
por: Alashkar, Ferras, et al.
Publicado: (2022)